Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
Submitted by
admin
on April 4, 2023 - 11:25pm
Source:
Motley Fool
News Tags:
Arrowhead Pharmaceuticals
Seres Therapeutics
Headline:
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
snippet:
Biotech stocks, on balance, had a rough 2022.
This broad-based sell-off might have created some once-in-a-lifetime buying opportunities.
Arrowhead Pharmaceuticals and Seres Therapeutics both screen as incredibly undervalued stocks right now.
Do Not Allow Advertisers to Use My Personal information
